7-(4-Methoxybenzylidene)-3-(4-chlorophenyl)-3,4-dihydro-2H-thiazolo[3,2-a][1,3,5]triazin-6(7H)-one

ID: ALA4555125

PubChem CID: 1311270

Max Phase: Preclinical

Molecular Formula: C19H16ClN3O2S

Molecular Weight: 385.88

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(/C=c2/sc3n(c2=O)CN(c2ccc(Cl)cc2)CN=3)cc1

Standard InChI:  InChI=1S/C19H16ClN3O2S/c1-25-16-8-2-13(3-9-16)10-17-18(24)23-12-22(11-21-19(23)26-17)15-6-4-14(20)5-7-15/h2-10H,11-12H2,1H3/b17-10+

Standard InChI Key:  CEPZIRGVYPRXDU-LICLKQGHSA-N

Molfile:  

 
     RDKit          2D

 26 29  0  0  0  0  0  0  0  0999 V2000
   16.7004  -24.9013    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4502  -24.1246    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1090  -23.6424    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   17.7719  -24.1246    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5119  -24.9041    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.0539  -25.5157    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8589  -25.3535    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.1190  -24.5740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5741  -23.9566    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.3995  -25.9615    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1382  -26.7370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6786  -27.3489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4805  -27.1867    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.7390  -26.4070    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1969  -25.7983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6729  -23.8724    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0659  -24.4195    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2894  -24.1648    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6827  -24.7111    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8527  -25.5113    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6348  -25.7623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2382  -25.2143    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2897  -25.6125    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.0225  -27.7982    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   13.2464  -26.0592    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.4687  -25.8081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  3  1  0
  4  5  1  0
  1  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  4  9  2  0
  7 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  2 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
  1 23  2  0
 13 24  1  0
 20 25  1  0
 25 26  1  0
M  END

Associated Targets(non-human)

NS5B Hepatitis C virus NS5B RNA-dependent RNA polymerase (3026 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hepatitis C virus (23859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 385.88Molecular Weight (Monoisotopic): 385.0652AlogP: 2.46#Rotatable Bonds: 3
Polar Surface Area: 46.83Molecular Species: NEUTRALHBA: 6HBD:
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 2.14CX LogP: 4.99CX LogD: 4.99
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.70Np Likeness Score: -1.52

References

1. Hassan GS, Georgey HH, Mohammed EZ, Omar FA..  (2019)  Anti-hepatitis-C virus activity and QSAR study of certain thiazolidinone and thiazolotriazine derivatives as potential NS5B polymerase inhibitors.,  184  [PMID:31604164] [10.1016/j.ejmech.2019.111747]

Source